The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report
Abstract
Share and Cite
Biernacka, B.; Krawczyk, P.; Buczkowski, J.; Siwiec, A.; Perżyło, K.; Milanowski, J. The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report. Adv. Respir. Med. 2010, 78, 192-202. https://doi.org/10.5603/ARM.27726
Biernacka B, Krawczyk P, Buczkowski J, Siwiec A, Perżyło K, Milanowski J. The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report. Advances in Respiratory Medicine. 2010; 78(3):192-202. https://doi.org/10.5603/ARM.27726
Chicago/Turabian StyleBiernacka, Beata, Paweł Krawczyk, Jarosław Buczkowski, Anna Siwiec, Katarzyna Perżyło, and Janusz Milanowski. 2010. "The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report" Advances in Respiratory Medicine 78, no. 3: 192-202. https://doi.org/10.5603/ARM.27726